Avalon BioVentures I, LP

Insider profile

Avalon BioVentures I, LP's trades of Janux Therapeutics, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
47.00
Quantity 30,613
Value US$1,438,811
Transaction date
Proposed sale
Price
45.52
Quantity 8,842
Value US$402,487
Transaction date
Proposed sale
Price
41.26
Quantity 20,991
Value US$866,088
Transaction date
Proposed sale
Price
54.96
Quantity 131,196
Value US$7,210,532
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-11-01 2024-11-01
PrS Proposed sale
74,984
95.66
US$2,791,706 		74,984 95.66 US$2,791,706
2024-10-25 2024-10-25
PrS Proposed sale
72,416
400.52
US$517,989 		72,416 400.52 US$517,989
2024-10-23 2024-10-23
PrS Proposed sale
6,932
256.07
US$546,993 		6,932 256.07 US$546,993
2024-10-18 2024-10-18
PrS Proposed sale
22,895
50.38
US$1,153,468 		22,895 50.38 US$1,153,468
2024-10-16 2024-10-16
PrS Proposed sale
17,367
49.96
US$867,595 		17,367 49.96 US$867,595
2024-09-27 2024-09-27
PrS Proposed sale
9,187
46.43
US$426,527 		9,187 46.43 US$426,527
2024-09-26 2024-09-26
PrS Proposed sale
17,500
47.19
US$825,743 		17,500 47.19 US$825,743
2024-09-12 2024-09-12
PrS Proposed sale
30,613
47.00
US$1,438,811 		30,613 47.00 US$1,438,811
2024-09-10 2024-09-10
PrS Proposed sale
8,842
45.52
US$402,487 		8,842 45.52 US$402,487
2024-09-06 2024-09-06
PrS Proposed sale
20,991
41.26
US$866,088 		20,991 41.26 US$866,088
2024-06-03 2024-06-03
PrS Proposed sale
131,196
54.96
US$7,210,532 		131,196 54.96 US$7,210,532